Model DetailsEye - Harderian gland neoplasm
Model Name |
Eye - Harderian gland neoplasm | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
Chemical/Drug, Bacteria : Helicobacter hepaticus • chloroprene |
Tumor Synonym |
Harderian gland: adenoma or carcinoma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Eye - Harderian gland | Male |
10% (5 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Male |
20% (10 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Male |
24% (12 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Male |
12% (6 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Male |
26.3% |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Male |
32% (16 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
10% (5 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
6% (3 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
18% (9 of 50 mice) |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
13.5% |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
11.7% |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |
| Eye - Harderian gland | Female |
31.2% |
110 weeks |
|
Melnick RL, Carcinogenesis 1999 May;20(5):867-78 |